F8 and hemophilia A: Although we used only one patient-derived iPSC line in this study, our gene correction strategy is applicable to a broad spectrum of FVIII mutations in hemophilia A, because the FVIII gene inserted at the patient’s FVIII locus is expressed regardless of FVIII mutant variation.